Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral tissue
- Molecular classification
- Other (not a molecule/receptor/enzyme/transporter), Includes multiple families: epithelial cells, connective tissues (fibroblasts/collagen), muscle cells/tissue types, nerve fibers/cells
01
Overview
Peripheral tissue refers broadly to all bodily tissues located outside of the central nervous system. This includes structures such as skin, subcutaneous fat, skeletal muscle fibers and capillaries supplying them with oxygen and nutrients; connective elements like tendons and ligaments; blood vessels; lymphatic channels; glands; sensory receptors in skin/organs; as well as all components of the peripheral nervous system including nerves that transmit signals between organs/limbs and CNS. These diverse structures play critical roles in physiological processes ranging from movement/exercise metabolism to sensation/perception/hormonal regulation. The term “peripheral tissue” does not denote any single protein/gene/receptor/enzyme but rather serves as an anatomical catch-all for non-CNS body compartments. As such it cannot be considered a canonical therapeutic target for drug development but rather describes locations where more specific molecular targets may reside.
- Other names
- Connective tissuesoft tissue
02
Biological functions
Insulin sensitivity and glucose uptake/metabolismOxygen diffusion/utilization in skeletal muscleSensory perception and motor function via peripheral nervesHormonal response/modulation in some cases (e.g., somatostatin expression)Structural support/protection/movement depending on specific peripheral tissue type
03
Disease associations
Infection (e.g., leprosy preferentially affects peripheral tissues such as skin/nerves)Cancer/soft-tissue sarcoma arises from various peripheral soft tissues like fat/muscle/fibrous/connective/nerves/blood vessels/lymphaticsMetabolic diseases involving insulin resistance/sensitivityNeurological disorders affecting the peripheral nervous system
04
Safety considerations
Non-specific targeting of “peripheral tissues” can lead to off-target effects due to their diversity and widespread distribution throughout the body.Toxicity concerns are highly dependent on which component of “peripheral tissue” is affected by therapy.Damage or dysfunction can result in metabolic disturbances, neuropathy, impaired wound healing or infection risk.
Beyond the preview
Go deeper on Peripheral tissue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peripheral tissue.